Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1

Therapy of autoimmune bullous diseases

Authors Diya F Mutasim

Published 15 March 2007 Volume 2007:3(1) Pages 29—40

Diya F Mutasim

Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Abstract: Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling inflammation and improving healing of erosions. The therapeutic agents used in the treatment of bullous diseases may be associated with high morbidity and occasional mortality. Successful treatment requires understanding of the pathophysiology of the disease process and the pharmacology of the drugs being used.  

Keywords: autoimmune, bullous, therapy

Download Article [PDF] 

Readers of this article also read:

Physicochemical properties, cytotoxicity, and antimicrobial activity of sulphated zirconia nanoparticles

Mftah A, Alhassan FH, Al-Qubaisi MS, El Zowalaty ME, Webster TJ, Sh-eldin M, Rasedee A, Taufiq-Yap YH, Rashid SS

International Journal of Nanomedicine 2015, 10:765-774

Published Date: 19 January 2015

Biodistribution, kinetics, and biological fate of SPION microbubbles in the rat

Barrefelt A, Saghafian M, Kuiper R, Ye F, Egri G, Klickermann M, Brismar TB, Aspelin P, Muhammed M, Dähne L, Hassan M

International Journal of Nanomedicine 2013, 8:3241-3254

Published Date: 26 August 2013

Entrapment in phospholipid vesicles quenches photoactivity of quantum dots

Generalov R, Kavaliauskiene S, Westrøm S, Chen W, Kristensen S, Juzenas P

International Journal of Nanomedicine 2011, 6:1875-1888

Published Date: 7 September 2011

Adverse effects of fullerenes on endothelial cells: Fullerenol C60(OH)24 induced tissue factor and ICAM-1 membrane expression and apoptosis in vitro

Monique P Gelderman, Olga Simakova, Jeffrey D Clogston, Anil K Patri, Sheena F Siddiqui, et al

International Journal of Nanomedicine 2008, 3:59-68

Published Date: 7 March 2008

Treatment of phantom bite syndrome with milnacipran - a case series

Akira Toyofuku, Toshihiro Kikuta

Neuropsychiatric Disease and Treatment 2006, 2:387-390

Published Date: 15 September 2006

Chitosan nanoparticles for oral drug and gene delivery

Katherine Bowman, Kam W Leong

International Journal of Nanomedicine 2006, 1:117-128

Published Date: 15 June 2006

Spatial control over cell attachment by partial solvent entrapment of poly lysine in microfluidic channels

Nicki K Baman, Galen B Schneider, Treniece L Terry, Rebecca Zaharias, Aliasger K Salem

International Journal of Nanomedicine 2006, 1:213-217

Published Date: 15 June 2006